Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Individualized survival prediction for patients with oropharyngeal cancer in the human papillomavirus era.

Beesley LJ, Hawkins PG, Amlani LM, Bellile EL, Casper KA, Chinn SB, Eisbruch A, Mierzwa ML, Spector ME, Wolf GT, Shuman AG, Taylor JMG.

Cancer. 2018 Oct 6. doi: 10.1002/cncr.31739. [Epub ahead of print]

PMID:
30291798
2.

Predictors of intratonsillar abscess versus peritonsillar abscess in the pediatric patient.

Ahmed Ali S, Kovatch KJ, Smith J, Bellile EL, Hanks JE, Truesdale CM, Hoff PT.

Int J Pediatr Otorhinolaryngol. 2018 Nov;114:143-146. doi: 10.1016/j.ijporl.2018.08.042. Epub 2018 Sep 5.

PMID:
30262353
3.

Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer.

Manohar PM, Beesley LJ, Bellile EL, Worden FP, Avram AM.

Clin Nucl Med. 2018 Sep;43(9):641-647. doi: 10.1097/RLU.0000000000002193.

PMID:
30015659
4.

Redefining Perineural Invasion: Integration of Biology With Clinical Outcome.

Schmitd LB, Beesley LJ, Russo N, Bellile EL, Inglehart RC, Liu M, Romanowicz G, Wolf GT, Taylor JMG, D'Silva NJ.

Neoplasia. 2018 Jul;20(7):657-667. doi: 10.1016/j.neo.2018.04.005. Epub 2018 May 23.

5.

Individualized outcome prognostication for patients with laryngeal cancer.

Hoban CW, Beesley LJ, Bellile EL, Sun Y, Spector ME, Wolf GT, Taylor JMG, Shuman AG.

Cancer. 2018 Feb 15;124(4):706-716. doi: 10.1002/cncr.31087. Epub 2017 Nov 7.

PMID:
29112231
6.

Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo.

DaSilva AF, Nascimento TD, Jassar H, Heffernan J, Toback RL, Lucas S, DosSantos MF, Bellile EL, Boonstra PS, Taylor JMG, Casey KL, Koeppe RA, Smith YR, Zubieta JK.

Neurology. 2017 Apr 25;88(17):1634-1641. doi: 10.1212/WNL.0000000000003861. Epub 2017 Mar 29.

7.

Family history of cancer and head and neck cancer survival.

Getz KR, Rozek LS, Peterson LA, Bellile EL, Taylor JMG, Wolf GT, Mondul AM.

Laryngoscope. 2017 Aug;127(8):1816-1820. doi: 10.1002/lary.26524. Epub 2017 Mar 7.

8.

Statistical controversies in clinical research: building the bridge to phase II-efficacy estimation in dose-expansion cohorts.

Boonstra PS, Braun TM, Taylor JMG, Kidwell KM, Bellile EL, Daignault S, Zhao L, Griffith KA, Lawrence TS, Kalemkerian GP, Schipper MJ.

Ann Oncol. 2017 Jul 1;28(7):1427-1435. doi: 10.1093/annonc/mdx045.

9.

Individualized risk prediction of outcomes for oral cavity cancer patients.

Prince V, Bellile EL, Sun Y, Wolf GT, Hoban CW, Shuman AG, Taylor JM.

Oral Oncol. 2016 Dec;63:66-73. doi: 10.1016/j.oraloncology.2016.11.005. Epub 2016 Nov 23.

10.

High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV.

Walline HM, Carey TE, Goudsmit CM, Bellile EL, D'Souza G, Peterson LA, McHugh JB, Pai SI, Lee JJ, Shin DM, Ferris RL; HNC SPORE HIV supplement consortium.

Mol Cancer Res. 2017 Feb;15(2):179-188. doi: 10.1158/1541-7786.MCR-16-0255. Epub 2016 Nov 29.

11.

Feasibility of Non-invasive Brain Modulation for Management of Pain Related to Chemoradiotherapy in Patients with Advanced Head and Neck Cancer.

Hu XS, Fisher CA, Munz SM, Toback RL, Nascimento TD, Bellile EL, Rozek L, Eisbruch A, Worden FP, Danciu TE, DaSilva AF.

Front Hum Neurosci. 2016 Sep 27;10:466. eCollection 2016.

12.

Cigarette use, comorbidities, and prognosis in a prospective head and neck squamous cell carcinoma population.

Peterson LA, Bellile EL, Wolf GT, Virani S, Shuman AG, Taylor JM, Rozek LS; University of Michigan Head and Neck Specialized Program of Research Excellence Program.

Head Neck. 2016 Dec;38(12):1810-1820. doi: 10.1002/hed.24515. Epub 2016 Jul 19.

13.

Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma.

Walline HM, Komarck CM, McHugh JB, Bellile EL, Brenner JC, Prince ME, McKean EL, Chepeha DB, Wolf GT, Worden FP, Bradford CR, Carey TE.

Mol Cancer Res. 2016 Oct;14(10):941-952. Epub 2016 Jul 15.

14.

In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model.

Rudy SF, Brenner JC, Harris JL, Liu J, Che J, Scott MV, Owen JH, Komarck CM, Graham MP, Bellile EL, Bradford CR, Prince ME, Carey TE.

J Otolaryngol Head Neck Surg. 2016 Apr 26;45:26. doi: 10.1186/s40463-016-0140-8.

15.

Pretreatment serum xanthophyll concentrations as predictors of head and neck cancer recurrence and survival.

Arthur AE, Bellile EL, Rozek LS, Peterson KE, Ren J, Harris E, Mueller C, Jolly S, Peterson LA, Wolf GT, Djuric Z.

Head Neck. 2016 Apr;38 Suppl 1:E1591-7. doi: 10.1002/hed.24283. Epub 2015 Nov 28.

16.

Sarcopenia is associated with autologous transplant-related outcomes in patients with lymphoma.

Caram MV, Bellile EL, Englesbe MJ, Terjimanian M, Wang SC, Griggs JJ, Couriel D.

Leuk Lymphoma. 2015;56(10):2855-62. doi: 10.3109/10428194.2015.1014359. Epub 2015 Jun 18.

PMID:
25739940
17.

Carboplatin-pemetrexed in treatment of patients with recurrent/metastatic cancers of the head and neck; superior outcomes in oropharyngeal primaries.

Malhotra B, Bellile EL, Nguyen NP, Fung VK, Slack M, Bilich R, Papagerakis S, Worden F.

Front Oncol. 2015 Jan 26;4:362. doi: 10.3389/fonc.2014.00362. eCollection 2014.

18.

Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells.

Krishnamurthy S, Warner KA, Dong Z, Imai A, Nör C, Ward BB, Helman JI, Taichman RS, Bellile EL, McCauley LK, Polverini PJ, Prince ME, Wicha MS, Nör JE.

Stem Cells. 2014 Nov;32(11):2845-57. doi: 10.1002/stem.1793.

19.

Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma.

Arthur AE, Peterson KE, Shen J, Djuric Z, Taylor JM, Hebert JR, Duffy SA, Peterson LA, Bellile EL, Whitfield JR, Chepeha DB, Schipper MJ, Wolf GT, Rozek LS.

Cancer. 2014 Sep 1;120(17):2704-12. doi: 10.1002/cncr.28778. Epub 2014 May 15.

20.

Epigenetic alterations in metastatic cutaneous carcinoma.

Darr OA, Colacino JA, Tang AL, McHugh JB, Bellile EL, Bradford CR, Prince MP, Chepeha DB, Rozek LS, Moyer JS.

Head Neck. 2015 Jul;37(7):994-1001. doi: 10.1002/hed.23701. Epub 2014 Jun 27.

21.

Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.

Chinn SB, Spector ME, Bellile EL, Rozek LS, Lin T, Teknos TN, Prince ME, Bradford CR, Urba SG, Carey TE, Eisbruch A, Wolf GT, Worden FP, Chepeha DB.

JAMA Otolaryngol Head Neck Surg. 2014 Feb;140(2):134-42. doi: 10.1001/jamaoto.2013.5892.

22.

Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma.

Chinn SB, Spector ME, Bellile EL, McHugh JB, Gernon TJ, Bradford CR, Wolf GT, Eisbruch A, Chepeha DB.

Otolaryngol Head Neck Surg. 2013 Dec;149(6):893-9. doi: 10.1177/0194599813506867. Epub 2013 Oct 23.

23.

Bayesian random threshold estimation in a Cox proportional hazards cure model.

Zhao L, Feng D, Bellile EL, Taylor JM.

Stat Med. 2014 Feb 20;33(4):650-61. doi: 10.1002/sim.5964. Epub 2013 Sep 6.

24.

CT perfusion can predict overexpression of CXCL8 (interleukin-8) in head and neck squamous cell carcinoma.

Jo SY, Wang PI, Nör JE, Bellile EL, Zhang Z, Worden FP, Srinivasan A, Mukherji SK.

AJNR Am J Neuroradiol. 2013 Dec;34(12):2338-42. doi: 10.3174/ajnr.A3610. Epub 2013 Jul 4.

Supplemental Content

Loading ...
Support Center